Product Information
RYTARY ER 36.25 MG-145 MG CAP is a brand product labeled by Amneal Pharmaceuticals LLC, priced at $3.9777 per EA under NDC 64896066201. Its NADAC has been published 562 times since Sep 23, 2015.
The High Outlier badge above means this manufacturer's average price in the Carbidopa and Levodopa market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
36.25; 145 mg/1; mg/1
Manufacturer
Amneal Pharmaceuticals LLCNDC
64896066201
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CARBIDOPA HYDRATE; LEVODOPAApproval Type
New Drug (NDA)
FDA Application
NDA203312On Market Since
1/12/2015
Pharmacological Classes
Price Statistics
The NADAC for RYTARY ER 36.25 MG-145 MG CAP has been published 562 times since Sep 23, 2015, and over the history we have for it it has risen 78.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.9777 per EA |
|---|---|
| All-time high | $3.9949 (Mar 13, 2024) |
| All-time low | $2.2337 (Sep 23, 2015) |
| 52-week high | $3.9817 |
| 52-week low | $3.9755 |
| Median price | $3.2107 |
| Average price | $3.2711 |
| Largest weekly change | +9.9% (Jan 9, 2019) |
| Weeks tracked | 562 |
| Tracking since | Sep 23, 2015 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 30% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RYTARY ER 36.25 MG-145 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for RYTARY ER 36.25 MG-145 MG CAP, manufactured by Amneal Pharmaceuticals LLC, is $3.9777 per EA (NDC 64896066201), effective Jun 24, 2026.
How has the price of RYTARY ER 36.25 MG-145 MG CAP changed over time?
Over the history we have for it, the NADAC for RYTARY ER 36.25 MG-145 MG CAP has risen 78.1%. It has been tracked across 562 weekly CMS publications since Sep 23, 2015.
What are the highest and lowest recorded NADAC prices for RYTARY ER 36.25 MG-145 MG CAP?
Since Sep 23, 2015, the NADAC for RYTARY ER 36.25 MG-145 MG CAP has ranged from a low of $2.2337 (Sep 23, 2015) to a high of $3.9949 (Mar 13, 2024), with a median of $3.2107 per EA.
Are there cheaper alternatives to RYTARY ER 36.25 MG-145 MG CAP?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, RYTARY ER 36.25 MG-145 MG CAP, is $2.7870 per EA — about 30% below RYTARY ER 36.25 MG-145 MG CAP.
Who manufactures RYTARY ER 36.25 MG-145 MG CAP?
RYTARY ER 36.25 MG-145 MG CAP (NDC 64896066201) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification